PGY vs. NKTR
PGY (Pagaya Technologies Ltd.) and NKTR (Nektar Therapeutics) are both stocks. PGY operates in Software - Infrastructure (Technology), while NKTR operates in Biotechnology (Healthcare). Over the past 3 years, PGY returned 2.43%/yr vs 96.12%/yr for NKTR. At a 0.24 correlation, their price movements are largely independent.
Performance
PGY vs. NKTR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PGY achieves a -27.80% return, which is significantly lower than NKTR's 55.39% return.
PGY
- 1D
- -3.39%
- 1M
- 18.26%
- YTD
- -27.80%
- 6M
- -35.24%
- 1Y
- -18.30%
- 3Y*
- 2.43%
- 5Y*
- —
- 10Y*
- —
NKTR
- 1D
- 7.74%
- 1M
- -1.37%
- YTD
- 55.39%
- 6M
- 51.10%
- 1Y
- 672.03%
- 3Y*
- 96.12%
- 5Y*
- -23.46%
- 10Y*
- -11.21%
PGY vs. NKTR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
PGY Pagaya Technologies Ltd. | -27.80% | 124.97% | -43.90% | 11.29% | -82.29% |
NKTR Nektar Therapeutics | 55.39% | 203.08% | 64.60% | -75.00% | -41.15% |
Correlation
The correlation between PGY and NKTR is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2022 | 0.24 |
Fundamentals
PGY:
$1.46B
NKTR:
$1.63B
PGY:
$1.06
NKTR:
-$8.64
PGY:
1.07
NKTR:
21.61
PGY:
2.76
NKTR:
2.82
PGY:
$1.30B
NKTR:
$55.63M
PGY:
$396.55M
NKTR:
$44.58M
PGY:
$180.28M
NKTR:
-$121.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PGY vs. NKTR — Risk / Return Rank
PGY
NKTR
PGY vs. NKTR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pagaya Technologies Ltd. (PGY) and Nektar Therapeutics (NKTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PGY | NKTR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.96 | ||
| Sortino ratioReturn per unit of downside risk | -6.61 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.77 | -0.74 |
| Calmar ratioReturn relative to maximum drawdown | -0.24 | 14.58 | -14.82 |
| Martin ratioReturn relative to average drawdown | -0.36 | 31.29 | -31.65 |
Loading charts...
Drawdowns
PGY vs. NKTR - Drawdown Comparison
The maximum PGY drawdown since its inception was -98.09%, roughly equal to the maximum NKTR drawdown of -99.61%. Use the drawdown chart below to compare losses from any high point for PGY and NKTR.
Loading charts...
Drawdown Indicators
| PGY | NKTR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.09% | -99.61% | +1.52% |
Max Drawdown (1Y)Largest decline over 1 year | -75.71% | -46.54% | -29.17% |
Max Drawdown (3Y)Largest decline over 3 years | -75.71% | -73.20% | -2.51% |
Max Drawdown (5Y)Largest decline over 5 years | — | -97.76% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.61% | — |
Current DrawdownCurrent decline from peak | -95.80% | -95.96% | +0.16% |
Average DrawdownAverage peak-to-trough decline | -92.12% | -68.35% | -23.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 50.31% | 21.64% | +28.67% |
Volatility
PGY vs. NKTR - Volatility Comparison
Pagaya Technologies Ltd. (PGY) has a higher volatility of 22.84% compared to Nektar Therapeutics (NKTR) at 14.13%. This indicates that PGY's price experiences larger fluctuations and is considered to be riskier than NKTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PGY | NKTR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.84% | 14.13% | +8.71% |
Volatility (6M)Calculated over the trailing 6-month period | 56.12% | 60.65% | -4.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.38% | 181.99% | -101.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 144.33% | 121.87% | +22.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.33% | 97.20% | +47.13% |
Dividends
PGY vs. NKTR - Dividend Comparison
Neither PGY nor NKTR has paid dividends to shareholders.
Financials
PGY vs. NKTR - Financials Comparison
This section allows you to compare key financial metrics between Pagaya Technologies Ltd. and Nektar Therapeutics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PGY and NKTR have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PGY has higher volatility (22.84%) compared to NKTR (14.13%). In terms of maximum drawdown, PGY dropped -98.09% vs NKTR's -99.61%.
NKTR currently has the higher Sharpe Ratio (3.73 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PGY and NKTR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer